MWM
BSX icon

Marion Wealth Management’s Boston Scientific BSX Stock Holding History

Marion Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,266
Closed -$205K – 161
2026
Q1 		$205K Buy
3,266
+347
+12% +$27.8K 0.05% 143
2025
Q4 		$270K Buy
2,919
+328
+13% +$32.2K 0.06% 121
2025
Q3 		$253K Buy
2,591
+30
+1% +$3.11K 0.06% 119
2025
Q2 		$275K Buy
2,561
+166
+7% +$16.8K 0.07% 115
2025
Q1 		$242K Buy
2,395
+133
+6% +$13.4K 0.06% 115
2024
Q4 		$202K Buy
+2,262
New +$199K 0.05% 129

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Marion Wealth Management's BSX Position: Q2 2026 in Review

Marion Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,266 shares — an estimated $205K sold.

Marion Wealth Management first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $275K in Q2 2025. 174 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Marion Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Marion Wealth Management sold 3,266 Boston Scientific shares in Q2 2026, an estimated $205K.
  • Marion Wealth Management first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
  • Marion Wealth Management's Boston Scientific position peaked at $275K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Marion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.